Relapsed / Refractory Myelodysplastic Syndromes
1 clinical trials · Condition
◉ Watch Relapsed / Refractory Myelodysplastic Syndromes
| Record | Firm | Date |
|---|---|---|
| A Trial to Evaluate the Safety and Efficacy of NK Cells in Subjects With Myelodysplastic Syndromes (NCT05371730) | Nuwacell Biotechnologies Co., Ltd. | 2022-05-30 |
Track Relapsed / Refractory Myelodysplastic Syndromes automatically
Every clearance here is in the API, with alerts when new ones post.